Aromatase inhibitors, cardiovascular medications, and patient outcomes - Authors' reply

Marie Lund; Giulia Corn; Maj-Britt Jensen; Tonny Petersen; Kim Dalhoff; Bent Ejlertsen; Lars Køber; Jan Wohlfahrt; Mads Melbye

doi:10.1016/S1470-2045(25)00013-0

Aromatase inhibitors, cardiovascular medications, and patient outcomes - Authors' reply

Marie Lund^*, Giulia Corn, Maj-Britt Jensen, Tonny Petersen, Kim Dalhoff, Bent Ejlertsen, Lars Køber, Jan Wohlfahrt, Mads Melbye

^*Corresponding author for this work

Original language	English
Journal	The Lancet Oncology
Volume	26
Issue number	2
Pages (from-to)	e75
ISSN	1470-2045
DOIs	https://doi.org/10.1016/S1470-2045(25)00013-0
Publication status	Published - Feb 2025

Access to Document

10.1016/S1470-2045(25)00013-0

Cite this

@article{1dbc8612daee4649bed7b9e95712d604,

title = "Aromatase inhibitors, cardiovascular medications, and patient outcomes - Authors' reply",

author = "Marie Lund and Giulia Corn and Maj-Britt Jensen and Tonny Petersen and Kim Dalhoff and Bent Ejlertsen and Lars K{\o}ber and Jan Wohlfahrt and Mads Melbye",

year = "2025",

month = feb,

doi = "10.1016/S1470-2045(25)00013-0",

language = "English",

volume = "26",

pages = "e75",

journal = "The Lancet Oncology",

issn = "1470-2045",

publisher = "Elsevier Limited",

number = "2",

}

TY - JOUR

T1 - Aromatase inhibitors, cardiovascular medications, and patient outcomes - Authors' reply

AU - Lund, Marie

AU - Corn, Giulia

AU - Jensen, Maj-Britt

AU - Petersen, Tonny

AU - Dalhoff, Kim

AU - Ejlertsen, Bent

AU - Køber, Lars

AU - Wohlfahrt, Jan

AU - Melbye, Mads

PY - 2025/2

Y1 - 2025/2

UR - https://www.scopus.com/pages/publications/85216552083

U2 - 10.1016/S1470-2045(25)00013-0

DO - 10.1016/S1470-2045(25)00013-0

M3 - Letter

C2 - 39914425

SN - 1470-2045

VL - 26

SP - e75

JO - The Lancet Oncology

JF - The Lancet Oncology

IS - 2

ER -

Aromatase inhibitors, cardiovascular medications, and patient outcomes - Authors' reply

Access to Document

Other files and links

Cite this